Form 4 for BSX Boston Scientific
Accepted 2025-04-02 00:00:00 ET · period of report 2025-04-01 · accession 0001225208-25-003866 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-02 | 2025-04-01 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $100.01 | -164.4K | 1.59M | -9% | -$16.45M |
| DM | 2025-04-02 | 2025-04-01 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $20.67 | +105.6K | 1.71M | +7% | +$2.18M |
| DM | 2025-04-02 | 2025-04-01 | BSX | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | -105.6K | 112.4K | -48% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-01 | S | D | 164,442 | $100.01 | 1,594,530 | D | — | — | (F2) Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $99.50 to $100.40, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2025-04-01 | M | A | 49,407 | $24.55 | 1,758,972 | D | — | — | |
| 3 | Common | Common Stock | 2025-04-01 | M | A | 56,211 | $17.26 | 1,709,565 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2025-04-01 | M | D | 49,407 | $0.00 | 247,035 | D | $24.55 · — to 2027-02-28 | 49,407 Common Stock | (F4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2018, the first anniversary of the date of grant. |
| 5 | Derivative | Stock Option (Right to Buy) | 2025-04-01 | M | D | 56,211 | $0.00 | 112,424 | D | $17.26 · — to 2026-02-22 | 56,211 Common Stock | (F3) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant. |